{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:14:05Z","timestamp":1792012445495,"version":"4.4.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018932","name":"Huai'an Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["HAB202209"],"award-info":[{"award-number":["HAB202209"]}],"id":[{"id":"10.13039\/100018932","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303865"],"award-info":[{"award-number":["82303865"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.gendis.2024.101376","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T14:07:01Z","timestamp":1721052421000},"page":"101376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Lipid metabolism involved in progression and drug resistance of breast cancer"],"prefix":"10.1016","volume":"12","author":[{"given":"Wenxiang","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.gendis.2024.101376_bib1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/cancers11070965","article-title":"Targeting cancer stem cells in triple-negative breast cancer","volume":"11","author":"Park","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/bjc.2017.379","article-title":"Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity","volume":"118","author":"Reddy","year":"2018","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.gendis.2024.101376_bib3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s42255-023-00786-y","article-title":"Physiological and pathological roles of lipogenesis","volume":"5","author":"Jeon","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.gendis.2024.101376_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7880448","article-title":"Neuropsychiatric ramifications of COVID-19: short-chain fatty acid deficiency and disturbance of microbiota-gut-brain axis signaling","volume":"2021","author":"Sajdel-Sulkowska","year":"2021","journal-title":"BioMed Res Int"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer","volume":"31","author":"Thor Snaebjornsson","year":"2020","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib6","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201606","article-title":"Lipid metabolism and cancer","volume":"218","author":"Bian","year":"2021","journal-title":"J Exp Med"},{"issue":"22","key":"10.1016\/j.gendis.2024.101376_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213933","article-title":"Mitochondrial fatty acid \u03b2-oxidation disorders: from disease to lipidomic studies \u2013 a critical review","volume":"23","author":"Guerra","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gendis.2024.101376_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115591","article-title":"Targeting fatty acid uptake and metabolism in cancer cells: a promising strategy for cancer treatment","volume":"167","author":"Mallick","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"10.1016\/j.gendis.2024.101376_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41574-019-0256-9","article-title":"The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state","volume":"15","author":"Hodson","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"72","key":"10.1016\/j.gendis.2024.101376_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.272re3","article-title":"CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior","volume":"2","author":"Silverstein","year":"2009","journal-title":"Sci Signal"},{"issue":"4","key":"10.1016\/j.gendis.2024.101376_bib11","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3892\/or.2017.5864","article-title":"Exogenous lipids promote the growth of breast cancer cells via CD36","volume":"38","author":"Zhao","year":"2017","journal-title":"Oncol Rep"},{"issue":"11","key":"10.1016\/j.gendis.2024.101376_bib12","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1016\/j.celrep.2019.11.008","article-title":"CD36-mediated metabolic rewiring of breast cancer cells promotes resistance to HER2-targeted therapies","volume":"29","author":"Feng","year":"2019","journal-title":"Cell Rep"},{"issue":"44","key":"10.1016\/j.gendis.2024.101376_bib13","doi-asserted-by":"crossref","first-page":"27412","DOI":"10.1073\/pnas.2002997117","article-title":"Blocking PPAR\u03b3 interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression","volume":"117","author":"Yang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.gendis.2024.101376_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1124\/molpharm.122.000607","article-title":"Ferroptosis, acyl starvation, and breast cancer","volume":"103","author":"Bobi\u0144ski","year":"2023","journal-title":"Mol Pharmacol"},{"issue":"9","key":"10.1016\/j.gendis.2024.101376_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s11626-014-9780-z","article-title":"Functional analysis of FABP3 in the milk fat synthesis signaling pathway of dairy cow mammary epithelial cells","volume":"50","author":"Liang","year":"2014","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50531-3","article-title":"Unraveling FATP1, regulated by ER-\u03b2, as a targeted breast cancer innovative therapy","volume":"9","author":"Mendes","year":"2019","journal-title":"Sci Rep"},{"issue":"Pt B","key":"10.1016\/j.gendis.2024.101376_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mce.2017.01.031","article-title":"Breast cancer metabolic cross-talk: fibroblasts are hubs and breast cancer cells are gatherers of lipids","volume":"462","author":"Lopes-Coelho","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"10.1016\/j.gendis.2024.101376_bib18","doi-asserted-by":"crossref","first-page":"992","DOI":"10.4149\/neo_2020_191017N1050","article-title":"Energy transfer from adipocytes to cancer cells in breast cancer","volume":"67","author":"Kim","year":"2020","journal-title":"Neoplasma"},{"issue":"11","key":"10.1016\/j.gendis.2024.101376_bib19","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.3390\/ijms19113434","article-title":"Solute carrier family 27 member 4 (SLC27A4) enhances cell growth, migration, and invasion in breast cancer cells","volume":"19","author":"Yen","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12964-018-0221-6","article-title":"Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression","volume":"16","author":"Yang","year":"2018","journal-title":"Cell Commun Signal"},{"issue":"3","key":"10.1016\/j.gendis.2024.101376_bib21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.7150\/ijms.29946","article-title":"New insight on solute carrier family 27 member 6 (SLC27A6) in tumoral and non-tumoral breast cells","volume":"16","author":"Yen","year":"2019","journal-title":"Int J Med Sci"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib22","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s42003-023-04987-9","article-title":"NFYA promotes malignant behavior of triple-negative breast cancer in mice through the regulation of lipid metabolism","volume":"6","author":"Okada","year":"2023","journal-title":"Commun Biol"},{"issue":"2","key":"10.1016\/j.gendis.2024.101376_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4132\/jptm.2021.10.27","article-title":"Fatty acid synthetase expression in triple-negative breast cancer","volume":"56","author":"Park","year":"2022","journal-title":"J Pathol Transl Med"},{"issue":"2","key":"10.1016\/j.gendis.2024.101376_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bbrc.2020.05.172","article-title":"Transcriptomic and cellular analyses of CRISPR\/Cas9-mediated edition of FASN show inhibition of aggressive characteristics in breast cancer cells","volume":"529","author":"Gonzalez-Salinas","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.gendis.2024.101376_bib25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s43018-021-00183-y","article-title":"Fatty acid synthesis is required for breast cancer brain metastasis","volume":"2","author":"Ferraro","year":"2021","journal-title":"Nat Cancer"},{"issue":"39","key":"10.1016\/j.gendis.2024.101376_bib26","doi-asserted-by":"crossref","first-page":"63679","DOI":"10.18632\/oncotarget.11626","article-title":"Leucine deprivation inhibits proliferation and induces apoptosis of human breast cancer cells via fatty acid synthase","volume":"7","author":"Xiao","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Metab"},{"issue":"9","key":"10.1016\/j.gendis.2024.101376_bib28","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.celrep.2016.02.004","article-title":"Fatty acid oxidation-driven Src links mitochondrial energy reprogramming and oncogenic properties in triple-negative breast cancer","volume":"14","author":"Park","year":"2016","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.gendis.2024.101376_bib29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s41388-020-01574-8","article-title":"MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer","volume":"40","author":"Han","year":"2021","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.gendis.2024.101376_bib30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nm.4055","article-title":"Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer","volume":"22","author":"Camarda","year":"2016","journal-title":"Nat Med"},{"issue":"7\u20138","key":"10.1016\/j.gendis.2024.101376_bib31","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1002\/jcp.29523","article-title":"Expression and clinicopathological significance of lipin-1 in human breast cancer and its association with p53 tumor suppressor gene","volume":"235","author":"Dinarvand","year":"2020","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib32","article-title":"SRC promotes lipogenesis: implications for obesity and breast cancer","volume":"8","author":"Lin","year":"2021","journal-title":"Mol Cell Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib33","first-page":"34","article-title":"RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer","volume":"10","author":"Li","year":"2023","journal-title":"Mil Med Res"},{"issue":"10","key":"10.1016\/j.gendis.2024.101376_bib34","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/ajcn\/34.10.2295","article-title":"Biochemical controls of liver cholesterol biosynthesis","volume":"34","author":"Ott","year":"1981","journal-title":"Am J Clin Nutr"},{"issue":"1\u20133","key":"10.1016\/j.gendis.2024.101376_bib35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/ars.2023.0340","article-title":"Cholesterol metabolism in cancer and cell death","volume":"39","author":"Chen","year":"2023","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"10.1016\/j.gendis.2024.101376_bib36","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41418-018-0158-8","article-title":"SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1\/2","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Death Differ"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib37","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1038\/s41467-019-12529-3","article-title":"ROR\u03b3 is a targetable master regulator of cholesterol biosynthesis in a cancer subtype","volume":"10","author":"Cai","year":"2019","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.gendis.2024.101376_bib38","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/cas.15710","article-title":"ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP-2 signaling","volume":"114","author":"Hwang","year":"2023","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12967-023-04236-x","article-title":"NUCB2\/Nesfatin-1 drives breast cancer metastasis through the up-regulation of cholesterol synthesis via the mTORC1 pathway","volume":"21","author":"Ning","year":"2023","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.gendis.2024.101376_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10549-021-06213-8","article-title":"NSDHL promotes triple-negative breast cancer metastasis through the TGF\u03b2 signaling pathway and cholesterol biosynthesis","volume":"187","author":"Chen","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.gendis.2024.101376_bib41","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.3892\/or.2020.7802","article-title":"STARD4 promotes breast cancer cell malignancy","volume":"44","author":"Zhang","year":"2020","journal-title":"Oncol Rep"},{"issue":"4","key":"10.1016\/j.gendis.2024.101376_bib42","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3390\/ijms21041356","article-title":"Cholesterol, oxysterols and LXRs in breast cancer pathophysiology","volume":"21","author":"Nazih","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gendis.2024.101376_bib43","article-title":"The emerging role of 27-hydroxycholesterol in cancer development and progression: an update","volume":"110","author":"Abdalkareem","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"6162","key":"10.1016\/j.gendis.2024.101376_bib44","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.1241908","article-title":"27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology","volume":"342","author":"Nelson","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib45","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41467-017-00910-z","article-title":"The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells","volume":"8","author":"Baek","year":"2017","journal-title":"Nat Commun"},{"issue":"16","key":"10.1016\/j.gendis.2024.101376_bib46","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1038\/s41388-021-01720-w","article-title":"Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer","volume":"40","author":"Hutchinson","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.gendis.2024.101376_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105834","article-title":"Ether lipid and sphingolipid expression patterns are estrogen receptor-dependently altered in breast cancer cells","volume":"127","author":"Hahnefeld","year":"2020","journal-title":"Int J Biochem Cell Biol"},{"issue":"7","key":"10.1016\/j.gendis.2024.101376_bib48","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/ATVBAHA.113.301498","article-title":"Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor \u03b32 suppression","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.gendis.2024.101376_bib49","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/ijc.29542","article-title":"Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells","volume":"137","author":"Kong","year":"2015","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yexcr.2014.12.017","article-title":"C6 ceramide dramatically enhances docetaxel-induced growth inhibition and apoptosis in cultured breast cancer cells: a mechanism study","volume":"332","author":"Yang","year":"2015","journal-title":"Exp Cell Res"},{"issue":"17","key":"10.1016\/j.gendis.2024.101376_bib51","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.3390\/ijms20174292","article-title":"C2-ceramide-induced Rb-dominant senescence-like phenotype leads to human breast cancer MCF-7 escape from p 53-dependent cell death","volume":"20","author":"Chang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gendis.2024.101376_bib52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.carres.2014.10.006","article-title":"Analysis of breast cancer-associated glycosphingolipids using electrospray ionization-linear ion trap quadrupole mass spectrometry","volume":"402","author":"Zhu","year":"2015","journal-title":"Carbohydr Res"},{"issue":"23","key":"10.1016\/j.gendis.2024.101376_bib53","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1158\/0008-5472.CAN-14-1651","article-title":"Globo-H ceramide shed from cancer cells triggers translin-associated factor X-dependent angiogenesis","volume":"74","author":"Cheng","year":"2014","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.gendis.2024.101376_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084191","article-title":"Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule","volume":"8","author":"Owczarek","year":"2013","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.gendis.2024.101376_bib55","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1007\/s00018-018-2799-7","article-title":"UDP-glucose ceramide glucosyltransferase activates AKT, promoted proliferation, and doxorubicin resistance in breast cancer cells","volume":"75","author":"Wegner","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"10.1016\/j.gendis.2024.101376_bib56","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.21873\/anticanres.16593","article-title":"Ganglioside GD2 expression is associated with unfavorable prognosis in early triple-negative breast cancer","volume":"43","author":"Higashi","year":"2023","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.gendis.2024.101376_bib57","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41416-021-01636-y","article-title":"Metabolic stress induces GD2+ cancer stem cell-like phenotype in triple-negative breast cancer","volume":"126","author":"Jaggupilli","year":"2022","journal-title":"Br J Cancer"},{"issue":"13","key":"10.1016\/j.gendis.2024.101376_bib58","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1073\/pnas.1302825110","article-title":"Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells","volume":"110","author":"Liang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.gendis.2024.101376_bib59","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1172\/JCI59735","article-title":"Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis","volume":"122","author":"Battula","year":"2012","journal-title":"J Clin Investig"},{"issue":"12","key":"10.1016\/j.gendis.2024.101376_bib60","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1158\/1535-7163.MCT-18-0399","article-title":"ST8SIA1 regulates tumor growth and metastasis in TNBC by activating the FAK-AKT-mTOR signaling pathway","volume":"17","author":"Nguyen","year":"2018","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10.1016\/j.gendis.2024.101376_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196369","article-title":"TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines","volume":"13","author":"Dewald","year":"2018","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.gendis.2024.101376_bib62","doi-asserted-by":"crossref","first-page":"36936","DOI":"10.18632\/oncotarget.16294","article-title":"IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells","volume":"8","author":"Battula","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.gendis.2024.101376_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/jcm5020013","article-title":"Epithelial-mesenchymal transition and breast cancer","volume":"5","author":"Wu","year":"2016","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.gendis.2024.101376_bib64","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbalip.2018.12.011","article-title":"A specific lipid metabolic profile is associated with the epithelial mesenchymal transition program","volume":"1864","author":"Giudetti","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.gendis.2024.101376_bib65","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fonc.2019.00145","article-title":"Spheroid-induced epithelial-mesenchymal transition provokes global alterations of breast cancer lipidome: a multi-layered omics analysis","volume":"9","author":"Kang","year":"2019","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.gendis.2024.101376_bib66","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41419-019-1303-0","article-title":"Sphingomyelin synthase 2 promotes an aggressive breast cancer phenotype by disrupting the homoeostasis of ceramide and sphingomyelin","volume":"10","author":"Zheng","year":"2019","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.gendis.2024.101376_bib67","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3892\/or.2020.7661","article-title":"TGF-\u03b21-induced epithelial-mesenchymal transition increases fatty acid oxidation and OXPHOS activity via the p-AMPK pathway in breast cancer cells","volume":"44","author":"Liu","year":"2020","journal-title":"Oncol Rep"},{"issue":"5","key":"10.1016\/j.gendis.2024.101376_bib68","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac040","article-title":"Al-MPS obstructs EMT in breast cancer by inhibiting lipid metabolism via miR-215-5p\/SREBP1","volume":"163","author":"Wu","year":"2022","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib69","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13045-019-0778-6","article-title":"Cancer-associated adipocytes: key players in breast cancer progression","volume":"12","author":"Wu","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"8","key":"10.1016\/j.gendis.2024.101376_bib70","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1172\/JCI127201","article-title":"Adipocyte and lipid metabolism in cancer drug resistance","volume":"129","author":"Cao","year":"2019","journal-title":"J Clin Investig"},{"issue":"10","key":"10.1016\/j.gendis.2024.101376_bib71","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41419-023-06230-z","article-title":"Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy","volume":"14","author":"Huang","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.gendis.2024.101376_bib72","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.acr.2019.03.002","article-title":"From immune checkpoints to vaccines: the past, present and future of cancer immunotherapy","volume":"143","author":"Osipov","year":"2019","journal-title":"Adv Cancer Res"},{"issue":"7","key":"10.1016\/j.gendis.2024.101376_bib73","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cmet.2023.06.003","article-title":"Beggars banquet: metabolism in the tumor immune microenvironment and cancer therapy","volume":"35","author":"Zou","year":"2023","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.gendis.2024.101376_bib74","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1021\/acscentsci.8b00932","article-title":"Mapping and profiling lipid distribution in a 3D model of breast cancer progression","volume":"5","author":"Vidavsky","year":"2019","journal-title":"ACS Cent Sci"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib75","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2085432","article-title":"Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression","volume":"11","author":"Liu","year":"2022","journal-title":"Oncoimmunology"},{"issue":"8","key":"10.1016\/j.gendis.2024.101376_bib76","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.3390\/ijms23084240","article-title":"Multifunctional role of lipids in modulating the tumorigenic properties of 4T1 breast cancer cells","volume":"23","author":"He","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10.1016\/j.gendis.2024.101376_bib77","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.3390\/cancers13235871","article-title":"MCF-7 drug resistant cell lines switch their lipid metabolism to triple negative breast cancer signature","volume":"13","author":"Adri\u00e1-Cebri\u00e1n","year":"2021","journal-title":"Cancers"},{"issue":"19","key":"10.1016\/j.gendis.2024.101376_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101848","article-title":"A CD10-OGP membrane peptolytic signaling axis in fibroblasts regulates lipid metabolism of cancer stem cells via SCD1","volume":"8","author":"Yu","year":"2021","journal-title":"Adv Sci"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib79","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cmet.2019.10.013","article-title":"STAT3 activation-induced fatty acid oxidation in CD8+ T effector cells is critical for obesity-promoted breast tumor growth","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib80","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/21623945.2021.1979758","article-title":"The paracrine effects of adipocytes on lipid metabolism in doxorubicin-treated triple negative breast cancer cells","volume":"10","author":"Mentoor","year":"2021","journal-title":"Adipocyte"},{"issue":"2","key":"10.1016\/j.gendis.2024.101376_bib81","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3390\/ijms24020946","article-title":"Cpt1c downregulation causes plasma membrane remodelling and anthracycline resistance in breast cancer","volume":"24","author":"Muley","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gendis.2024.101376_bib82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ebiom.2018.12.037","article-title":"Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis","volume":"40","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.gendis.2024.101376_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110870","article-title":"Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids","volume":"39","author":"Li","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.gendis.2024.101376_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1014798","article-title":"Metabolomic profiling of triple negative breast cancer cells suggests that valproic acid can enhance the anticancer effect of cisplatin","volume":"10","author":"Granit","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"22","key":"10.1016\/j.gendis.2024.101376_bib85","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJM199811263392207","article-title":"Tamoxifen in the treatment of breast cancer","volume":"339","author":"Osborne","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib86","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1186\/s12885-018-4757-z","article-title":"Association of tamoxifen resistance and lipid reprogramming in breast cancer","volume":"18","author":"Hultsch","year":"2018","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.gendis.2024.101376_bib87","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.coph.2012.09.007","article-title":"Cholesterol metabolism and resistance to tamoxifen","volume":"12","author":"Poirot","year":"2012","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"10.1016\/j.gendis.2024.101376_bib88","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s13577-023-00977-5","article-title":"The role of mitochondrial\/metabolic axis in development of tamoxifen resistance in breast cancer","volume":"36","author":"Azzam","year":"2023","journal-title":"Hum Cell"},{"issue":"2","key":"10.1016\/j.gendis.2024.101376_bib89","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.gendis.2024.101376_bib90","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41419-023-06181-5","article-title":"Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer","volume":"14","author":"Jiang","year":"2023","journal-title":"Cell Death Dis"},{"issue":"6382","key":"10.1016\/j.gendis.2024.101376_bib91","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.gendis.2024.101376_bib92","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","article-title":"Acquired resistance to immune checkpoint inhibitors","volume":"37","author":"Schoenfeld","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.gendis.2024.101376_bib93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s13402-017-0353-5","article-title":"Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells","volume":"41","author":"Luu","year":"2018","journal-title":"Cell Oncol"},{"issue":"9","key":"10.1016\/j.gendis.2024.101376_bib94","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005068","article-title":"Restoration of p53 activity via intracellular protein delivery sensitizes triple negative breast cancer to anti-PD-1 immunotherapy","volume":"10","author":"Yang","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"10371","key":"10.1016\/j.gendis.2024.101376_bib95","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(22)02420-5","article-title":"Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial","volume":"401","author":"Hurvitz","year":"2023","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.gendis.2024.101376_bib96","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/membranes13060540","article-title":"Lipid metabolism reprogramming and trastuzumab resistance in breast cancer cell lines overexpressing the ERBB2 membrane receptor","volume":"13","author":"Cortese","year":"2023","journal-title":"Membranes"},{"issue":"5","key":"10.1016\/j.gendis.2024.101376_bib97","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.mehy.2004.09.027","article-title":"Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells","volume":"64","author":"Menendez","year":"2005","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1016\/j.gendis.2024.101376_bib98","article-title":"CD36: a key mediator of resistance to HER2 inhibitors in breast cancer","volume":"7","author":"Feng","year":"2020","journal-title":"Mol Cell Oncol"},{"issue":"5","key":"10.1016\/j.gendis.2024.101376_bib99","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2419","article-title":"PD 0332991, a selective cyclin D kinase 4\/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro","volume":"11","author":"Finn","year":"2009","journal-title":"Breast Cancer Res"},{"issue":"20","key":"10.1016\/j.gendis.2024.101376_bib100","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa1607303","article-title":"Palbociclib and letrozole in advanced breast cancer","volume":"375","author":"Finn","year":"2016","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.gendis.2024.101376_bib101","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1200\/JCO.18.00925","article-title":"Cyclin E1 expression and palbociclib efficacy in previously treated hormone receptor-positive metastatic breast cancer","volume":"37","author":"Turner","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304224001739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304224001739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:08:42Z","timestamp":1762618122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304224001739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2352304224001739"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2024.101376","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid metabolism involved in progression and drug resistance of breast cancer","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2024.101376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd\u00e9","name":"copyright","label":"Copyright"}],"article-number":"101376"}}